Literature DB >> 26843195

Cardiac fibrosis detected by magnetic resonance imaging on predicting time course diversity of left ventricular reverse remodeling in patients with idiopathic dilated cardiomyopathy.

Yuki Ikeda1, Takayuki Inomata2, Teppei Fujita1, Yuichiro Iida1, Takeru Nabeta1, Shunsuke Ishii1, Emi Maekawa1, Tomoyoshi Yanagisawa1, Tomohiro Mizutani1, Takashi Naruke1, Toshimi Koitabashi1, Ichiro Takeuchi1, Junya Ako1.   

Abstract

This study aimed to identify the association between the time course of left ventricular reverse remodeling (LVRR) and late gadolinium enhancement in cardiac magnetic resonance imaging (LGE-cMRI) in patients with idiopathic dilated cardiomyopathy (IDCM). We identified 214 IDCM patients treated by optimal pharmacotherapies. LVRR was defined as ≥10 % increment in LV ejection fraction along with ≥10 % reduction in LV end-diastolic dimension. Findings of LGE-cMRI focusing on presence and extent of LGE were evaluated at baseline. Echocardiographic evaluation for detecting LVRR was performed in all patients for 3 years. The primary endpoint was defined as composite events (CEs) including readmission for heart failure, detection of major ventricular arrhythmia, and all-cause mortality. LVRR was found at <1 year in 59 patients (28 %, early responder), ≥1 year in 56 patients (26 %, late responder), and was absent in 99 patients (46 %, non-responder). Multivariate Cox-proportional hazards analysis revealed that both early responders (P = 0.02) and late responders (P < 0.001) had lower incidence of CEs than non-responders. Among 66 subjects (23 %) with complete cMRI evaluation, LGE was detected more often in late and non- than early responders (65, 83 vs. 23 % P < 0.001, respectively), whereas the LGE area was smaller in both early and late than non-responders (2 ± 3, 4 ± 3 vs. 12 ± 10 %, P < 0.001, respectively). In conclusion, evaluating the presence and the extent of LGE is useful for predicting the clinical differences of LVRR time course and subsequent long-term outcomes.

Entities:  

Keywords:  Cardiac function; Fibrosis; Prognosis; Remodeling

Mesh:

Substances:

Year:  2016        PMID: 26843195     DOI: 10.1007/s00380-016-0805-2

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  29 in total

1.  Histopathologic findings in explanted heart tissue from patients with end-stage idiopathic dilated cardiomyopathy.

Authors:  N de Leeuw; D J Ruiter; A H Balk; N de Jonge; W J Melchers; J M Galama
Journal:  Transpl Int       Date:  2001-09       Impact factor: 3.782

2.  Cardiac resynchronization in chronic heart failure.

Authors:  William T Abraham; Westby G Fisher; Andrew L Smith; David B Delurgio; Angel R Leon; Evan Loh; Dusan Z Kocovic; Milton Packer; Alfredo L Clavell; David L Hayes; Myrvin Ellestad; Robin J Trupp; Jackie Underwood; Faith Pickering; Cindy Truex; Peggy McAtee; John Messenger
Journal:  N Engl J Med       Date:  2002-06-13       Impact factor: 91.245

3.  Guidelines for treatment of acute heart failure (JCS 2011).

Authors: 
Journal:  Circ J       Date:  2013-06-12       Impact factor: 2.993

4.  Replacement and reactive myocardial fibrosis in idiopathic dilated cardiomyopathy: comparison of magnetic resonance imaging with right ventricular biopsy.

Authors:  Simon Schalla; Sebastiaan C Bekkers; Robert Dennert; Robert J van Suylen; Johannes Waltenberger; Tim Leiner; Joachim Wildberger; Harry J Crijns; Stephane Heymans
Journal:  Eur J Heart Fail       Date:  2010-03       Impact factor: 15.534

5.  ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 appropriate use criteria for implantable cardioverter-defibrillators and cardiac resynchronization therapy: a report of the American College of Cardiology Foundation appropriate use criteria task force, Heart Rhythm Society, American Heart Association, American Society of Echocardiography, Heart Failure Society of America, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance.

Authors:  Andrea M Russo; Raymond F Stainback; Steven R Bailey; Andrew E Epstein; Paul A Heidenreich; Mariell Jessup; Suraj Kapa; Mark S Kremers; Bruce D Lindsay; Lynne Warner Stevenson
Journal:  J Am Coll Cardiol       Date:  2013-03-01       Impact factor: 24.094

6.  Prevalence, predictors, and prognosis of reversal of maladaptive remodeling with intensive medical therapy in idiopathic dilated cardiomyopathy.

Authors:  K Kawai; H Takaoka; K Hata; Y Yokota; M Yokoyama
Journal:  Am J Cardiol       Date:  1999-09-15       Impact factor: 2.778

7.  Idiopathic dilated cardiomyopathy: analysis of 152 necropsy patients.

Authors:  W C Roberts; R J Siegel; B M McManus
Journal:  Am J Cardiol       Date:  1987-12-01       Impact factor: 2.778

8.  Bisoprolol vs. carvedilol in elderly patients with heart failure: rationale and design of the CIBIS-ELD trial.

Authors:  Hans-Dirk Düngen; Svetlana Apostolović; Simone Inkrot; Elvis Tahirović; Florian Krackhardt; Milan Pavlović; Biljana Putniković; Mitja Lainscak; Götz Gelbrich; Frank Edelmann; Rolf Wachter; Thomas Eschenhagen; Finn Waagstein; Ferenc Follath; Mathias Rauchhaus; Wilhelm Haverkamp; Karl-Josef Osterziel; Rainer Dietz
Journal:  Clin Res Cardiol       Date:  2008-06-09       Impact factor: 5.460

9.  Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy.

Authors:  Ankur Gulati; Andrew Jabbour; Tevfik F Ismail; Kaushik Guha; Jahanzaib Khwaja; Sadaf Raza; Kishen Morarji; Tristan D H Brown; Nizar A Ismail; Marc R Dweck; Elisa Di Pietro; Michael Roughton; Ricardo Wage; Yousef Daryani; Rory O'Hanlon; Mary N Sheppard; Francisco Alpendurada; Alexander R Lyon; Stuart A Cook; Martin R Cowie; Ravi G Assomull; Dudley J Pennell; Sanjay K Prasad
Journal:  JAMA       Date:  2013-03-06       Impact factor: 56.272

10.  Baseline cardiac magnetic resonance imaging versus baseline endomyocardial biopsy for the prediction of left ventricular reverse remodeling and prognosis in response to therapy in patients with idiopathic dilated cardiomyopathy.

Authors:  Takeru Nabeta; Takayuki Inomata; Yuichiro Iida; Yuki Ikeda; Miwa Iwamoto; Shunsuke Ishii; Takanori Sato; Ichiro Watanabe; Takashi Naruke; Hisahito Shinagawa; Toshimi Koitabashi; Ichiro Takeuchi; Mototsugu Nishii; Yusuke Inoue; Tohru Izumi
Journal:  Heart Vessels       Date:  2013-10-04       Impact factor: 2.037

View more
  16 in total

1.  Higher hemoglobin A1c levels are associated with impaired left ventricular diastolic function and higher incidence of adverse cardiac events in patients with nonischemic dilated cardiomyopathy.

Authors:  Yuki Ikeda; Takayuki Inomata; Teppei Fujita; Yuichiro Iida; Toyoji Kaida; Takeru Nabeta; Shunsuke Ishii; Emi Maekawa; Tomoyoshi Yanagisawa; Tomohiro Mizutani; Takashi Naruke; Toshimi Koitabashi; Ichiro Takeuchi; Junya Ako
Journal:  Heart Vessels       Date:  2016-09-26       Impact factor: 2.037

2.  Conditional knockout of activin like kinase-1 (ALK-1) leads to heart failure without maladaptive remodeling.

Authors:  Kevin J Morine; Xiaoying Qiao; Vikram Paruchuri; Mark J Aronovitz; Emily E Mackey; Lyanne Buiten; Jonathan Levine; Keshan Ughreja; Prerna Nepali; Robert M Blanton; Richard H Karas; S Paul Oh; Navin K Kapur
Journal:  Heart Vessels       Date:  2017-02-17       Impact factor: 2.037

3.  Left ventricular reverse remodeling is not related to biopsy-detected extracellular matrix fibrosis and serum markers of fibrosis in dilated cardiomyopathy, regardless of the definition used for LVRR.

Authors:  Paweł Rubiś; Sylwia Wiśniowska-Śmiałek; Barbara Biernacka-Fijałkowska; Lucyna Rudnicka-Sosin; Ewa Wypasek; Artur Kozanecki; Ewa Dziewięcka; Patrycja Faltyn; Aleksandra Karabinowska; Lusine Khachatryan; Marta Hlawaty; Agata Leśniak-Sobelga; Magdalena Kostkiewicz; Wojciech Płazak; Piotr Podolec
Journal:  Heart Vessels       Date:  2016-12-21       Impact factor: 2.037

4.  Clinical significance of discrepant mid-wall late gadolinium enhancement in patients with nonischemic dilated cardiomyopathy.

Authors:  Shoichi Ehara; Kenji Matsumoto; Ryoko Kitada; Satoshi Nishimura; Kenei Shimada; Minoru Yoshiyama
Journal:  Heart Vessels       Date:  2018-05-26       Impact factor: 2.037

5.  Extracellular volume fraction assessed using cardiovascular magnetic resonance can predict improvement in left ventricular ejection fraction in patients with dilated cardiomyopathy.

Authors:  Keisuke Inui; Kuniya Asai; Masaki Tachi; Aya Yoshinaga; Yuki Izumi; Yoshiaki Kubota; Koji Murai; Yayoi Tetsuou Tsukada; Yasuo Amano; Shinichiro Kumita; Wataru Shimizu
Journal:  Heart Vessels       Date:  2018-03-20       Impact factor: 2.037

Review 6.  Multimodality imaging assessment of mitral valve anatomy in planning for mitral valve repair in secondary mitral regurgitation.

Authors:  Romain Capoulade; Nicolas Piriou; Jean-Michel Serfaty; Thierry Le Tourneau
Journal:  J Thorac Dis       Date:  2017-06       Impact factor: 2.895

7.  In-hospital management and outcomes in patients with peripartum cardiomyopathy: a descriptive study using a national inpatient database in Japan.

Authors:  Toshiaki Isogai; Hiroki Matsui; Hiroyuki Tanaka; Kiyohide Fushimi; Hideo Yasunaga
Journal:  Heart Vessels       Date:  2017-02-23       Impact factor: 2.037

8.  Late gadolinium enhancement on cardiac magnetic resonance imaging is associated with coronary endothelial dysfunction in patients with dilated cardiomyopathy.

Authors:  Mina Nakayama; Megumi Yamamuro; Seiji Takashio; Tomoaki Uemura; Naoki Nakayama; Kyoko Hirakawa; Seitaro Oda; Daisuke Utsunomiya; Koichi Kaikita; Seiji Hokimoto; Yasuyuki Yamashita; Yukiko Morita; Kazuo Kimura; Kouichi Tamura; Kenichi Tsujita
Journal:  Heart Vessels       Date:  2017-10-19       Impact factor: 2.037

9.  ZBTB17 loss-of-function mutation contributes to familial dilated cardiomyopathy.

Authors:  Yu-Min Sun; Jun Wang; Ying-Jia Xu; Xin-Hua Wang; Fang Yuan; Hua Liu; Ruo-Gu Li; Min Zhang; Yan-Jie Li; Hong-Yu Shi; Liang Zhao; Xing-Biao Qiu; Xin-Kai Qu; Yi-Qing Yang
Journal:  Heart Vessels       Date:  2018-02-14       Impact factor: 1.814

10.  Magnetic resonance imaging of dilated cardiomyopathy: prognostic benefit of identifying late gadolinium enhancement in Asian patients.

Authors:  Anna Nogue Infante; Christopher Chieh Yang Koo; Alfred Yip; Ying Ha Lim; Wee Tiong Yeo; Swee Tian Quek; Toon Wei Lim; Swee Chong Seow; Ping Chai; Ching Ching Ong; Lynette Teo; Devinder Singh; Pipin Kojodjojo
Journal:  Singapore Med J       Date:  2019-12-10       Impact factor: 1.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.